ATAI logo

Atai Life Sciences N.V. (ATAI)

Profile

Full Name

Atai Life Sciences N.V.

Ticker

NASDAQ: ATAI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

June 18, 2021

Indexes

Not included

Website

https://atai.com

Employees

54

Key Details

Price

$5.78(-1.37%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$308.00K(-1.91% YoY)

Annual EPS

-$0.93(-268.09% YoY)

PE Ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.78
    ATAI price is $5.78

    30-Day Relative Volume

    0.61
    ATAI 30-day relative volume is 0.61

    Price Performance

    Price Most Recent Change

    -1.37%
    ATAI price was down -1.37% on Oct 30, 2025

    Price YTD Change

    +334.59%
    ATAI price is up +334.59% since January 1st

    Price 1-Year Change

    +416.07%
    ATAI price is up +416.07% year-on-year

    Price 3-Year Change

    +92.67%
    ATAI price is up +92.67% over the past 3 years

    Price Range

    Price All-Time High

    $22.91
    ATAI price is currently -74.77% below its historical high of $22.91

    Price 3-Year Low

    $1.02
    ATAI price is currently +463.90% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.35B
    ATAI market cap is $1.35 billion

    Market Cap 3-Year Change

    +171.54%
    ATAI market cap is up +171.54% over the past 3 years

    Market Cap All-Time High

    $3.03B
    ATAI market cap is currently -55.47% below its historical high of $3.03 billion

    Market Cap Sector Percentile

    74.47%
    ATAI market cap is higher than 74.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +39.31%
    ATAI shares outstanding is up +39.31% year-on-year

    Shares Outstanding 3-Year Change

    +40.94%
    ATAI shares outstanding is up +40.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.39
    ATAI beta is 1.39

    200-day SMA

    $2.92
    ATAI price is currently +97.86% above its 200-day simple moving average

    50-day SMA

    $5.19
    ATAI price is currently +11.27% above its 50-day simple moving average

    14-Day RSI

    53.11
    ATAI 14-day relative strength index is 53.11

    Volume

    0.61
    ATAI 30-day relative volume is 0.61

    ATR

    $0.43
    ATAI average true range is $0.43

    10-day Historical Volatility

    118.05%
    ATAI 10-day historical volatility is 118.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $308.00K
    ATAI annual revenue is $308.00 thousand

    Revenue Analysts Estimate

    $2.53M
    ATAI annual revenue is currently -87.81% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -1.91%
    ATAI annual revenue is down -1.91% year-on-year

    Revenue Sector Percentile

    33.56%
    ATAI annual revenue is higher than 33.56% of companies in Healthcare sector

    EPS

    EPS

    -$0.93
    ATAI annual earnings per share is -$0.93

    EPS Analysts Estimate

    -$0.52
    ATAI annual earnings per share is currently -80.10% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -268.09%
    ATAI annual earnings per share is down -268.09% year-on-year

    EPS Sector Percentile

    57.76%
    ATAI annual earnings per share is higher than 57.76% of companies in Healthcare sector

    Profit

    Gross Profit

    -$165.00K
    ATAI annual gross profit is -$165.00 thousand

    Gross Margin

    -53.57%
    ATAI annual gross profit margin is -53.57%

    Operating Profit

    -$102.17M
    ATAI annual operating income is -$102.17 million

    Operating Margin

    -33.34K%
    ATAI annual operating profit margin is -33.34 thousand%

    Net Income

    -$150.05M
    ATAI annual net profit is -$150.05 million

    Net Margin

    -48.46K%
    ATAI annual net profit margin is -48.46 thousand%

    Expenses

    Total Expenses

    $149.58M
    ATAI annual total expenses is $149.58 million

    Operating Expenses

    $102.53M
    ATAI annual total operating expenses is $102.53 million

    Cost Of Goods Sold

    $473.00K
    ATAI annual cost of goods sold is $473.00 thousand

    Selling, General & Administrative Expenses

    $47.54M
    ATAI annual SG&A is $47.54 million

    Depreciation & Amortization

    $473.00K
    ATAI annual D&A is $473.00 thousand

    Interest Expense

    $0.00
    ATAI annual interest expense is $0.00

    Income Tax

    -$881.00K
    ATAI annual income tax is -$881.00 thousand

    EBIT & EBITDA

    EBIT

    -$145.28M
    ATAI annual earnings before interest & taxes is -$145.28 million

    EBITDA

    -$144.81M
    ATAI annual EBITDA is -$144.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $159.39M
    ATAI annual total assets is $159.39 million

    Non Current Assets

    $79.26M
    ATAI annual long term assets is $79.26 million

    Current Assets

    $80.13M
    ATAI annual total current assets is $80.13 million

    Cash and Cash Equivalents

    $17.50M
    ATAI annual cash & cash equivalents is $17.50 million

    Accounts Receivable

    -
    ATAI annual accounts receivable value is unknown

    Inventory

    $0.00
    ATAI annual inventory is $0.00

    Liabilities

    Total Liabilities

    $42.83M
    ATAI annual total liabilities is $42.83 million

    Long Term Liabilities

    $17.88M
    ATAI annual total long term liabilities is $17.88 million

    Current Liabilities

    $24.95M
    ATAI annual current liabilities is $24.95 million

    Accounts Payable

    $2.62M
    ATAI annual accounts payable is $2.62 million

    Debt

    Total Debt

    $24.71M
    ATAI annual total debt is $24.71 million

    Total Debt 1-Year Change

    +49.95%
    ATAI annual total debt is up +49.95% year-on-year

    Long Term Debt

    $14.87M
    ATAI annual long term debt is $14.87 million

    Short Term Debt

    $9.84M
    ATAI annual short term debt is $9.84 million

    Equity & Capital

    Shareholders Equity

    $116.30M
    ATAI annual stockholders equity is $116.30 million

    Book Value

    $116.30M
    ATAI annual book value is $116.30 million

    Retained Earnings

    -$700.21M
    ATAI annual retained earnings is -$700.21 million

    Working Capital

    $55.17M
    ATAI annual working capital is $55.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$82.44M
    ATAI annual cash from operations is -$82.44 million

    Cash From Operations 1-Year Change

    +2%
    ATAI annual cash from operations is up +2% year-on-year

    Cash From Investing

    $59.17M
    ATAI annual cash from investing is $59.17 million

    Cash From Investing 1-Year Change

    +211.03%
    ATAI annual cash from investing is up +211.03% year-on-year

    Cash From Financing

    $5.37M
    ATAI annual cash from financing is $5.37 million

    Cash From Financing 1-Year Change

    +164.32%
    ATAI annual cash from financing is up +164.32% year-on-year

    CAPEX

    CAPEX

    $95.00K
    ATAI annual capital expenditures is $95.00 thousand

    CAPEX 1-Year Change

    -83.9%
    ATAI annual capital expenditures is down -83.9% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$82.53M
    ATAI annual free cash flow is -$82.53 million

    Free Cash Flow 1-Year Change

    +2.57%
    ATAI annual free cash flow is up +2.57% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -53.57%
    ATAI annual gross profit margin is -53.57%

    Operating Margin

    -33.34K%
    ATAI annual operating profit margin is -33.34 thousand%

    Net Margin

    -48.46K%
    ATAI annual net profit margin is -48.46 thousand%

    ROA & ROE

    ROA

    -66.27%
    ATAI annual return on assets is -66.27%

    ROE

    -83.16%
    ATAI annual return on equity is -83.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ATAI price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ATAI price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    9.40
    ATAI price to book ratio is 9.40

    PB Ratio Sector Percentile

    86.88%
    ATAI price to book ratio is higher than 86.88% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    585.21
    ATAI price to sales ratio is 585.21

    PS Ratio Sector Percentile

    95.76%
    ATAI price to sales ratio is higher than 95.76% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.26B
    ATAI enterprise value is $1.26 billion

    Enterprise Value Sector Percentile

    74.61%
    ATAI enterprise value is higher than 74.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -13.41
    ATAI EV/EBITDA is -13.41

    EV/EBITDA Sector Percentile

    11.75%
    ATAI EV/EBITDA is higher than 11.75% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.21
    ATAI annual current ratio is 3.21

    Quick Ratio

    3.21
    ATAI annual quick ratio is 3.21

    Leverage

    Debt To Equity

    0.20
    ATAI annual debt to equity ratio is 0.20

    Interest Coverage Ratio

    -
    ATAI annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    ATAI piotroski f-score is 3

    Altman Z-Score

    10.19
    ATAI altman z-score is 10.19

    Analyst ratings

    Recent major analysts updates

    Oct 22, 25 Canaccord Genuity
    Buy
    Oct 13, 25 Needham
    Buy
    Sep 23, 25 HC Wainwright & Co.
    Buy
    Jul 30, 25 HC Wainwright & Co.
    Buy
    Jul 29, 25 Oppenheimer
    Outperform
    Jul 28, 25 Canaccord Genuity
    Buy
    Jul 2, 25 Canaccord Genuity
    Buy
    May 20, 25 HC Wainwright & Co.
    Buy
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Feb 13, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ATAI included

    Growing Shares Outstanding
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Atai Life Sciences N.V.?
    • Does Atai Life Sciences N.V. pay dividends?
    • What sector is Atai Life Sciences N.V. in?
    • What industry is Atai Life Sciences N.V. in?
    • What country is Atai Life Sciences N.V. based in?
    • When did Atai Life Sciences N.V. go public?
    • Is Atai Life Sciences N.V. in the S&P 500?
    • Is Atai Life Sciences N.V. in the NASDAQ 100?
    • Is Atai Life Sciences N.V. in the Dow Jones?
    • When was Atai Life Sciences N.V.'s last earnings report?
    • When does Atai Life Sciences N.V. report earnings?

    What is the ticker symbol for Atai Life Sciences N.V.?

    The ticker symbol for Atai Life Sciences N.V. is NASDAQ:ATAI

    Does Atai Life Sciences N.V. pay dividends?

    No, Atai Life Sciences N.V. does not pay dividends

    What sector is Atai Life Sciences N.V. in?

    Atai Life Sciences N.V. is in the Healthcare sector

    What industry is Atai Life Sciences N.V. in?

    Atai Life Sciences N.V. is in the Biotechnology industry

    What country is Atai Life Sciences N.V. based in?

    Atai Life Sciences N.V. is headquartered in Germany

    When did Atai Life Sciences N.V. go public?

    Atai Life Sciences N.V.'s initial public offering (IPO) was on June 18, 2021

    Is Atai Life Sciences N.V. in the S&P 500?

    No, Atai Life Sciences N.V. is not included in the S&P 500 index

    Is Atai Life Sciences N.V. in the NASDAQ 100?

    No, Atai Life Sciences N.V. is not included in the NASDAQ 100 index

    Is Atai Life Sciences N.V. in the Dow Jones?

    No, Atai Life Sciences N.V. is not included in the Dow Jones index

    When was Atai Life Sciences N.V.'s last earnings report?

    Atai Life Sciences N.V.'s most recent earnings report was on August 14, 2025

    When does Atai Life Sciences N.V. report earnings?

    The next expected earnings date for Atai Life Sciences N.V. is November 13, 2025
    On this page